Sponsored diagnostic testing programs for Chronic Mucocutaneous Candidiasis
Chronic Mucocutaneous Candidiasis (CMC) is a primary immunodeficiency marked by persistent or recurrent Candida infections of the skin, nails, and mucous membranes. It is often caused by genetic variants that impair IL-17 immunity, leading to a selective vulnerability to fungal infections.
2 programs found for Chronic Mucocutaneous Candidiasis
Invitae Unlock™ Immunology provides clinicians with a comprehensive gene panel to evaluate patients with suspected primary immunodeficiency or immune-regulatory disorders. This no-charge program supports diagnostic clarification, aids in variant-guided care decisions, and can inform family cascade testing when appropriate.
Invitae Unlock Immunology offers sponsored access to the Inborn Errors of Immunity and Cytopenias Panel, Invitae’s most comprehensive assay for evaluating inherited immune disorders and cytopenias. The panel includes genes tied to combined immunodeficiencies, immune dysregulation, and bone marrow failure, supporting clearer diagnosis and management. U.S. providers may order for eligible patients.
